InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the complete record of transactions filed by Poole Sandra, 董事. Insider active across 1 company, notably Travere Therapeutics, Inc.. Aggregated, 5 filings have been logged. History available since 14 May 2021. The latest transaction was disclosed on 15 May 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Sandra Poole is a Director at Travere Therapeutics, Inc. She plays a key role in overseeing the company's activities and making strategic decisions. Her experience is valuable for guiding Travere towards sustainable growth and optimal performance.